Related Experiment Video
Updated: Jul 6, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
[Chronic lymphocytic leukaemia: current management]
T Aurran-Schleinitz1, C Arnoulet, V Ivanov
1Département d'onco-hématologie, institut Paoli-Calmettes, boulevard Sainte Marguerite, 13273 Marseille cedex 9, France. aurrant@marseille.fnclcc.fr
Introduction:
Chronic lymphocytic leukemia (CLL) is the most common leukaemia in the Western world. Recent advancement in the aetiology, pathophysiology and the development of new therapeutics tools have significantly modified the current management of CLL.
Current Knowledge And Key Points:
The cellular origin of CLL is still unknown. The current main hypothesis will be first briefly described. This review will then focus on the newly defined prognostic factors and the development and use of new drugs for the treatment of CLL. To describe the modern and practical management of CLL, we will compare classical and new prognostic markers. Then, we will discuss the various therapeutic options including chemotherapy and immunotherapy (monoclonal antibodies, allogenic transplantation), and define their current respective indications.
Future Prospects And Projects:
These new diagnostic and prognostic markers will allow the characterization of new prognostic subgroups of patients. This will lead to a targeted and individualized therapeutic approach. We will present the first results of clinical trials and the on-going studies conducted in this disease.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Pancreatitis II: Collaborative Care
Assessment:
Rheumatic Heart Disease III: Medical Management
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Myocarditis IV: Nursing Management
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
